{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T02:36:24Z","timestamp":1695609384566},"reference-count":23,"publisher":"Wiley","issue":"5-6","license":[{"start":{"date-parts":[[2002,1,30]],"date-time":"2002-01-30T00:00:00Z","timestamp":1012348800000},"content-version":"vor","delay-in-days":264,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2001,5,11]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1. Hypoadrenocorticism frequently results in critical hypotension, hypovolaemia, hyponatraemia and hyperkalaemia. Perhaps even more important, hypoadrenocorticoid humans experience decreased vasoconstriction in response to exogenous administration of vasoconstrictors, such as noradrenaline.<\/jats:p><jats:p>2. We studied chronically adrenalectomized adult sheep to test the hypothesis that the reduction in pressor responsiveness is the result of increased production of nitric oxide (NO) during hypoadrenocorticism.<\/jats:p><jats:p>3. Withdrawal of steroid replacement resulted in reduced blood pressure, reduced pressor responsiveness, as well as hyperkalaemia and hyponatraemia.<\/jats:p><jats:p>4. Inhibition of NO production by <jats:italic>N<\/jats:italic><jats:sup>G<\/jats:sup>\u2010nitro\u2010<jats:sc>L<\/jats:sc>\u2010arginine methyl ester in the hypoadrenocorticoid ewes restored mean arterial pressure and pressor responsiveness response to normal values.<\/jats:p><jats:p>5. The results of these experiments support the hypothesis that reduced pressor responsiveness in the hypoadrenocorticoid state is mediated by the overproduction of NO.<\/jats:p>","DOI":"10.1046\/j.1440-1681.2001.03475.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T11:11:05Z","timestamp":1047381065000},"page":"459-462","source":"Crossref","is-referenced-by-count":6,"title":["Nitric Oxide Reduces Pressor Responsiveness During Ovine Hypoadrenocorticism"],"prefix":"10.1111","volume":"28","author":[{"given":"Pini","family":"Orbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Keller\u2010Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,30]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-125-32212"},{"key":"e_1_2_6_3_2","first-page":"H1274","article-title":"Vascular responsiveness in adrenalectomized rats with corticosterone replacement.","volume":"256","author":"Darlington DN","year":"1989","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_4_2","unstructured":"LoriauxDL Adrenocortical Insufficiency.In: Becker KL (ed.).Principles and Practice of Endocrinology and Metabolism. JB Lippincott Philadelphia. 1990; 600\u20134."},{"key":"e_1_2_6_5_2","first-page":"109","article-title":"Nitric oxide: Physiology, pathophysiology, and pharmacology.","volume":"43","author":"Moncada S","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00141-0"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1998.tb02349.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.23.13357"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0739-7240(91)90060-W"},{"key":"e_1_2_6_10_2","first-page":"507","article-title":"Sheep model for study of maternal adrenal gland function during pregnancy.","volume":"48","author":"Keller\u2010Wood M","year":"1998","journal-title":"Lab. Anim. Sci."},{"key":"e_1_2_6_11_2","first-page":"R441","article-title":"Nitric oxide and pregnancy.","volume":"272","author":"Sladek SM","year":"1997","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.272.6.H2765"},{"key":"e_1_2_6_13_2","first-page":"H2264","article-title":"Estrogen replacement attenuates resistance artery adrenergic sensitivity via endothelial vasodilators.","volume":"272","author":"Meyer MC","year":"1997","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199407000-00022"},{"key":"e_1_2_6_15_2","first-page":"R858","article-title":"Fetal ACTH and blood pressure responses to thromboxane mimetic U46619.","volume":"265","author":"Wood CE","year":"1993","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_16_2","unstructured":"McCanceKL&HuetherSE.Pathophysiology: The Biologic Basis for Disease in Adults and Children.Mosby St Louis. 1997."},{"key":"e_1_2_6_17_2","unstructured":"BondyPK.Disorders of the adrenal cortex. In: Wilson JD Foster DW (eds).Williams\u2019 Textbook of Endocrinology. WB Saunders Philadelphia. 1985; 816\u201390."},{"key":"e_1_2_6_18_2","first-page":"15","article-title":"Glucocorticoids inhibit the induction of nitric oxide synthase II by down\u2010regulating cytokine\u2010induced activity of transcription factor nuclear factor\u2010kappa B.","volume":"49","author":"Kleinert H","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00075-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1124\/mol.54.2.258","article-title":"Expressional down\u2010regulation of neuronal\u2010type nitric oxide synthase I by glucocorticoids in N1E\u2010115 neuroblastoma cells.","volume":"54","author":"Schwarz PM","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","unstructured":"MangosGJ WalkerBR KellyJJ LawsonJA WebbDJ WhitworthJA.Cortisol inhibits cholinergic vasodilation in the human forearm.Am. J. Hypertens.2000;13: 1155\u201360.","DOI":"10.1016\/S0895-7061(00)01201-2"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1993.1010"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199606000-00020"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1998.tb02189.x"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1681.2001.03475.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1681.2001.03475.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T10:08:27Z","timestamp":1693476507000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1681.2001.03475.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,11]]},"references-count":23,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2001,5,11]]}},"alternative-id":["10.1046\/j.1440-1681.2001.03475.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1681.2001.03475.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,11]]}}}